Home » Analyst Articles – US

Image for Dave (NASDAQ:DAVE) Given “Outperform” Rating at Barrington Research

Dave (NASDAQ:DAVE) Given “Outperform” Rating at Barrington Research

Barrington Research reissued their outperform rating on shares of Dave (NASDAQ:DAVE – Free Report) in a report released on Tuesday morning,Benzinga reports. Barrington Research currently has a $290.00 price objective on the... More of this article »
Image for BridgeBio Pharma (NASDAQ:BBIO) Given New $94.00 Price Target at JPMorgan Chase & Co.

BridgeBio Pharma (NASDAQ:BBIO) Given New $94.00 Price Target at JPMorgan Chase & Co.

BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price objective increased by JPMorgan Chase & Co. from $89.00 to $94.00 in a report issued on Tuesday,Benzinga reports. They currently have an overweight rating on the... More of this article »
Image for Medline (NASDAQ:MDLN) Given New $53.00 Price Target at JPMorgan Chase & Co.

Medline (NASDAQ:MDLN) Given New $53.00 Price Target at JPMorgan Chase & Co.

Medline (NASDAQ:MDLN – Free Report) had its price objective increased by JPMorgan Chase & Co. from $50.00 to $53.00 in a research note published on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has... More of this article »
Image for HUTCHMED (NASDAQ:HCM) Given New $20.00 Price Target at Bank of America

HUTCHMED (NASDAQ:HCM) Given New $20.00 Price Target at Bank of America

HUTCHMED (NASDAQ:HCM – Free Report) had its target price trimmed by Bank of America from $21.00 to $20.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other... More of this article »
Image for argenex (NASDAQ:ARGX) Upgraded by Deutsche Bank Aktiengesellschaft to “Buy” Rating

argenex (NASDAQ:ARGX) Upgraded by Deutsche Bank Aktiengesellschaft to “Buy” Rating

Deutsche Bank Aktiengesellschaft upgraded shares of argenex (NASDAQ:ARGX – Free Report) from a hold rating to a buy rating in a research report released on Tuesday morning, Marketbeat.com reports. Several other research analysts... More of this article »
Image for Jefferies Financial Group Issues Positive Forecast for Palladyne AI (NASDAQ:PDYN) Stock Price

Jefferies Financial Group Issues Positive Forecast for Palladyne AI (NASDAQ:PDYN) Stock Price

Palladyne AI (NASDAQ:PDYN – Free Report) had its price objective boosted by Jefferies Financial Group from $7.00 to $8.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Jefferies Financial Group currently... More of this article »
Image for Marriott International (NASDAQ:MAR) Price Target Raised to $331.00 at Morgan Stanley

Marriott International (NASDAQ:MAR) Price Target Raised to $331.00 at Morgan Stanley

Marriott International (NASDAQ:MAR – Free Report) had its price target hoisted by Morgan Stanley from $328.00 to $331.00 in a research report report published on Tuesday,Benzinga reports. Morgan Stanley currently has an overweight... More of this article »
Image for Beachbody (NASDAQ:BODI) Given New $12.00 Price Target at Canaccord Genuity Group

Beachbody (NASDAQ:BODI) Given New $12.00 Price Target at Canaccord Genuity Group

Beachbody (NASDAQ:BODI – Free Report) had its target price raised by Canaccord Genuity Group from $9.00 to $12.00 in a research report sent to investors on Tuesday,Benzinga reports. Canaccord Genuity Group currently has a buy... More of this article »
Image for Evaxion A/S (NASDAQ:EVAX) Now Covered by Analysts at JonesTrading

Evaxion A/S (NASDAQ:EVAX) Now Covered by Analysts at JonesTrading

JonesTrading began coverage on shares of Evaxion A/S (NASDAQ:EVAX – Free Report) in a report released on Tuesday morning,Benzinga reports. The firm issued a buy rating and a $10.00 target price on the stock. EVAX has been the... More of this article »
Image for Casella Waste Systems (NASDAQ:CWST) Price Target Lowered to $130.00 at UBS Group

Casella Waste Systems (NASDAQ:CWST) Price Target Lowered to $130.00 at UBS Group

Casella Waste Systems (NASDAQ:CWST – Free Report) had its price target trimmed by UBS Group from $140.00 to $130.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has a buy rating... More of this article »
Image for Nature’s Sunshine Products (NASDAQ:NATR) Price Target Raised to $29.00 at Canaccord Genuity Group

Nature’s Sunshine Products (NASDAQ:NATR) Price Target Raised to $29.00 at Canaccord Genuity Group

Nature’s Sunshine Products (NASDAQ:NATR – Free Report) had its target price upped by Canaccord Genuity Group from $22.00 to $29.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Canaccord Genuity... More of this article »
Image for BioNTech (NASDAQ:BNTX) Price Target Lowered to $138.00 at Jefferies Financial Group

BioNTech (NASDAQ:BNTX) Price Target Lowered to $138.00 at Jefferies Financial Group

BioNTech (NASDAQ:BNTX – Free Report) had its price objective trimmed by Jefferies Financial Group from $151.00 to $138.00 in a research report released on Tuesday morning, Marketbeat.com reports. The brokerage currently has a... More of this article »
Image for lululemon athletica (NASDAQ:LULU) Receives “Market Perform” Rating from Telsey Advisory Group

lululemon athletica (NASDAQ:LULU) Receives “Market Perform” Rating from Telsey Advisory Group

Telsey Advisory Group restated their market perform rating on shares of lululemon athletica (NASDAQ:LULU – Free Report) in a research report report published on Tuesday morning,Benzinga reports. The brokerage currently has a... More of this article »
Image for Wells Fargo & Company Issues Positive Forecast for Casey’s General Stores (NASDAQ:CASY) Stock Price

Wells Fargo & Company Issues Positive Forecast for Casey’s General Stores (NASDAQ:CASY) Stock Price

Casey’s General Stores (NASDAQ:CASY – Free Report) had its target price increased by Wells Fargo & Company from $725.00 to $745.00 in a report issued on Tuesday morning,Benzinga reports. They currently have an overweight... More of this article »
Image for Raymond James Financial Issues Positive Forecast for Methanex (NASDAQ:MEOH) Stock Price

Raymond James Financial Issues Positive Forecast for Methanex (NASDAQ:MEOH) Stock Price

Methanex (NASDAQ:MEOH – Free Report) (TSE:MX) had its price objective boosted by Raymond James Financial from $45.00 to $50.00 in a research note released on Tuesday morning,BayStreet.CA reports. Raymond James Financial currently... More of this article »
Image for Editas Medicine (NASDAQ:EDIT) Upgraded by JonesTrading to “Buy” Rating

Editas Medicine (NASDAQ:EDIT) Upgraded by JonesTrading to “Buy” Rating

JonesTrading upgraded shares of Editas Medicine (NASDAQ:EDIT – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday,Benzinga reports. The firm currently has $8.00 price objective on... More of this article »
Image for Casey’s General Stores (NASDAQ:CASY) Price Target Raised to $780.00 at Jefferies Financial Group

Casey’s General Stores (NASDAQ:CASY) Price Target Raised to $780.00 at Jefferies Financial Group

Casey’s General Stores (NASDAQ:CASY – Free Report) had its price target lifted by Jefferies Financial Group from $700.00 to $780.00 in a research note published on Tuesday,Benzinga reports. The brokerage currently has a... More of this article »
Image for Distribution Solutions Group (NASDAQ:DSGR) Given New $35.00 Price Target at Barrington Research

Distribution Solutions Group (NASDAQ:DSGR) Given New $35.00 Price Target at Barrington Research

Distribution Solutions Group (NASDAQ:DSGR – Free Report) had its target price reduced by Barrington Research from $41.00 to $35.00 in a report released on Tuesday morning,Benzinga reports. Barrington Research currently has an... More of this article »
Image for Old Dominion Freight Line (NASDAQ:ODFL) Price Target Raised to $182.00 at JPMorgan Chase & Co.

Old Dominion Freight Line (NASDAQ:ODFL) Price Target Raised to $182.00 at JPMorgan Chase & Co.

Old Dominion Freight Line (NASDAQ:ODFL – Free Report) had its target price lifted by JPMorgan Chase & Co. from $168.00 to $182.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating... More of this article »
Image for Dollar Tree (NASDAQ:DLTR) Given “Outperform” Rating at Telsey Advisory Group

Dollar Tree (NASDAQ:DLTR) Given “Outperform” Rating at Telsey Advisory Group

Telsey Advisory Group reiterated their outperform rating on shares of Dollar Tree (NASDAQ:DLTR – Free Report) in a research note released on Tuesday,Benzinga reports. They currently have a $150.00 target price on the stock. Several... More of this article »
Image for Five Below (NASDAQ:FIVE) Receives Outperform Rating from Telsey Advisory Group

Five Below (NASDAQ:FIVE) Receives Outperform Rating from Telsey Advisory Group

Telsey Advisory Group reissued their outperform rating on shares of Five Below (NASDAQ:FIVE – Free Report) in a research note released on Tuesday,Benzinga reports. They currently have a $240.00 target price on the specialty... More of this article »
Image for Novo Nordisk A/S (NYSE:NVO) Downgraded by TD Cowen to “Hold”

Novo Nordisk A/S (NYSE:NVO) Downgraded by TD Cowen to “Hold”

TD Cowen lowered shares of Novo Nordisk A/S (NYSE:NVO – Free Report) from a buy rating to a hold rating in a research report released on Tuesday morning, MarketBeat.com reports. They currently have $42.00 target price on the... More of this article »
Image for JPMorgan Chase & Co. Issues Positive Forecast for Morgan Stanley (NYSE:MS) Stock Price

JPMorgan Chase & Co. Issues Positive Forecast for Morgan Stanley (NYSE:MS) Stock Price

Morgan Stanley (NYSE:MS – Free Report) had its price objective increased by JPMorgan Chase & Co. from $173.00 to $179.00 in a report issued on Tuesday morning,Benzinga reports. They currently have a neutral rating on the... More of this article »
Image for Western Alliance Bancorporation (NYSE:WAL) Given New $93.00 Price Target at DA Davidson

Western Alliance Bancorporation (NYSE:WAL) Given New $93.00 Price Target at DA Davidson

Western Alliance Bancorporation (NYSE:WAL – Free Report) had its price target reduced by DA Davidson from $105.00 to $93.00 in a research note published on Tuesday,Benzinga reports. DA Davidson currently has a buy rating on the... More of this article »
Image for MacroGenics (NASDAQ:MGNX) Price Target Raised to $4.00 at Barclays

MacroGenics (NASDAQ:MGNX) Price Target Raised to $4.00 at Barclays

MacroGenics (NASDAQ:MGNX – Free Report) had its target price boosted by Barclays from $3.00 to $4.00 in a research note issued to investors on Tuesday,Benzinga reports. Barclays currently has an overweight rating on the biopharmaceutical... More of this article »
Image for Gaming and Leisure Properties (NASDAQ:GLPI) Price Target Raised to $50.00 at Scotiabank

Gaming and Leisure Properties (NASDAQ:GLPI) Price Target Raised to $50.00 at Scotiabank

Gaming and Leisure Properties (NASDAQ:GLPI – Free Report) had its target price boosted by Scotiabank from $48.00 to $50.00 in a research report released on Tuesday morning,Benzinga reports. Scotiabank currently has a sector perform... More of this article »
Image for Citigroup Issues Positive Forecast for BioAge Labs (NASDAQ:BIOA) Stock Price

Citigroup Issues Positive Forecast for BioAge Labs (NASDAQ:BIOA) Stock Price

BioAge Labs (NASDAQ:BIOA – Free Report) had its target price boosted by Citigroup from $15.00 to $52.00 in a report released on Tuesday morning,Benzinga reports. Citigroup currently has a buy rating on the stock. BIOA has been... More of this article »
Image for Capricor Therapeutics (NASDAQ:CAPR) Receives “Buy” Rating from HC Wainwright

Capricor Therapeutics (NASDAQ:CAPR) Receives “Buy” Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Capricor Therapeutics (NASDAQ:CAPR – Free Report) in a research note published on Tuesday, Marketbeat.com reports. HC Wainwright currently has a $60.00 price objective on... More of this article »
Image for Citigroup Issues Positive Forecast for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price

Citigroup Issues Positive Forecast for Lexicon Pharmaceuticals (NASDAQ:LXRX) Stock Price

Lexicon Pharmaceuticals (NASDAQ:LXRX – Free Report) had its target price raised by Citigroup from $2.10 to $2.30 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical... More of this article »
Image for FuelCell Energy (NASDAQ:FCEL) Price Target Lowered to $6.00 at Wells Fargo & Company

FuelCell Energy (NASDAQ:FCEL) Price Target Lowered to $6.00 at Wells Fargo & Company

FuelCell Energy (NASDAQ:FCEL – Free Report) had its price objective lowered by Wells Fargo & Company from $7.00 to $6.00 in a report released on Tuesday,Benzinga reports. The firm currently has an underweight rating on the... More of this article »
Image for Qualcomm (NASDAQ:QCOM) Now Covered by Bank of America

Qualcomm (NASDAQ:QCOM) Now Covered by Bank of America

Bank of America began coverage on shares of Qualcomm (NASDAQ:QCOM – Free Report) in a research report sent to investors on Tuesday, Marketbeat.com reports. The brokerage issued an underperform rating and a $145.00 price target... More of this article »
Image for RideNow Group’s (RDNW) “Neutral” Rating Reaffirmed at DA Davidson

RideNow Group’s (RDNW) “Neutral” Rating Reaffirmed at DA Davidson

DA Davidson reaffirmed their neutral rating on shares of RideNow Group (NASDAQ:RDNW – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat.com reports. They currently have a $6.00 price objective... More of this article »
Image for Royal Bank Of Canada Issues Positive Forecast for Design Therapeutics (NASDAQ:DSGN) Stock Price

Royal Bank Of Canada Issues Positive Forecast for Design Therapeutics (NASDAQ:DSGN) Stock Price

Design Therapeutics (NASDAQ:DSGN – Free Report) had its price target raised by Royal Bank Of Canada from $13.00 to $14.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an outperform rating... More of this article »
Image for Byrna Technologies (NASDAQ:BYRN) Given New $31.00 Price Target at B. Riley Financial

Byrna Technologies (NASDAQ:BYRN) Given New $31.00 Price Target at B. Riley Financial

Byrna Technologies (NASDAQ:BYRN – Free Report) had its price target lowered by B. Riley Financial from $46.00 to $31.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a buy rating on the stock. Separately,... More of this article »
Image for CrowdStrike (NASDAQ:CRWD) Price Target Cut to $500.00 by Analysts at Daiwa Securities Group

CrowdStrike (NASDAQ:CRWD) Price Target Cut to $500.00 by Analysts at Daiwa Securities Group

CrowdStrike (NASDAQ:CRWD – Free Report) had its target price decreased by Daiwa Securities Group from $560.00 to $500.00 in a research note issued to investors on Tuesday,MarketScreener reports. Daiwa Securities Group currently... More of this article »
Image for Wolfe Research Issues Positive Forecast for CSX (NASDAQ:CSX) Stock Price

Wolfe Research Issues Positive Forecast for CSX (NASDAQ:CSX) Stock Price

CSX (NASDAQ:CSX – Free Report) had its target price raised by Wolfe Research from $42.00 to $44.00 in a research report released on Tuesday,MarketScreener reports. The firm currently has an outperform rating on the transportation... More of this article »
Image for Costco Wholesale (NASDAQ:COST) Price Target Raised to $975.00 at Daiwa Securities Group

Costco Wholesale (NASDAQ:COST) Price Target Raised to $975.00 at Daiwa Securities Group

Costco Wholesale (NASDAQ:COST – Free Report) had its price objective upped by Daiwa Securities Group from $917.00 to $975.00 in a research report sent to investors on Tuesday,MarketScreener reports. The brokerage currently has... More of this article »
Image for Intuit (NASDAQ:INTU) Rating Increased to Buy at Rothschild & Co Redburn

Intuit (NASDAQ:INTU) Rating Increased to Buy at Rothschild & Co Redburn

Rothschild & Co Redburn upgraded shares of Intuit (NASDAQ:INTU – Free Report) from a neutral rating to a buy rating in a research report released on Tuesday morning, Marketbeat Ratings reports. They currently have $700.00... More of this article »
Image for Dianthus Therapeutics (NASDAQ:DNTH) Upgraded by Raymond James Financial to Strong-Buy Rating

Dianthus Therapeutics (NASDAQ:DNTH) Upgraded by Raymond James Financial to Strong-Buy Rating

Raymond James Financial upgraded shares of Dianthus Therapeutics (NASDAQ:DNTH – Free Report) from an outperform rating to a strong-buy rating in a research note published on Tuesday, MarketBeat.com reports. They currently have... More of this article »
Image for Intchains Group (NASDAQ:ICG) Price Target Cut to $3.00 by Analysts at Benchmark

Intchains Group (NASDAQ:ICG) Price Target Cut to $3.00 by Analysts at Benchmark

Intchains Group (NASDAQ:ICG – Free Report) had its price target cut by Benchmark from $4.00 to $3.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock. A number of... More of this article »
Image for Nayax (NASDAQ:NYAX) Price Target Raised to $60.00 at Keefe, Bruyette & Woods

Nayax (NASDAQ:NYAX) Price Target Raised to $60.00 at Keefe, Bruyette & Woods

Nayax (NASDAQ:NYAX – Free Report) had its target price lifted by Keefe, Bruyette & Woods from $52.00 to $60.00 in a research note published on Tuesday morning,Benzinga reports. Keefe, Bruyette & Woods currently has... More of this article »
Image for Cellectar Biosciences (NASDAQ:CLRB) Rating Increased to Buy at Maxim Group

Cellectar Biosciences (NASDAQ:CLRB) Rating Increased to Buy at Maxim Group

Maxim Group upgraded shares of Cellectar Biosciences (NASDAQ:CLRB – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning, MarketBeat Ratings reports. Separately, Weiss Ratings reaffirmed a “sell... More of this article »
Image for LifeMD (NASDAQ:LFMD) Given Buy Rating at BTIG Research

LifeMD (NASDAQ:LFMD) Given Buy Rating at BTIG Research

BTIG Research reaffirmed their buy rating on shares of LifeMD (NASDAQ:LFMD – Free Report) in a research note published on Tuesday,Benzinga reports. They currently have a $10.00 price target on the stock. A number of other brokerages... More of this article »
Image for RideNow Group (NASDAQ:RDNW) Given New $7.00 Price Target at Robert W. Baird

RideNow Group (NASDAQ:RDNW) Given New $7.00 Price Target at Robert W. Baird

RideNow Group (NASDAQ:RDNW – Free Report) had its target price lifted by Robert W. Baird from $5.00 to $7.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a neutral rating on the stock. Several... More of this article »
Image for Crocs (NASDAQ:CROX) Now Covered by Analysts at BTIG Research

Crocs (NASDAQ:CROX) Now Covered by Analysts at BTIG Research

BTIG Research began coverage on shares of Crocs (NASDAQ:CROX – Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The brokerage issued a neutral rating on the textile maker’s stock. Several other research... More of this article »
Image for Wedbush Issues Positive Forecast for Dianthus Therapeutics (NASDAQ:DNTH) Stock Price

Wedbush Issues Positive Forecast for Dianthus Therapeutics (NASDAQ:DNTH) Stock Price

Dianthus Therapeutics (NASDAQ:DNTH – Free Report) had its price target upped by Wedbush from $55.00 to $80.00 in a report published on Tuesday,Benzinga reports. The firm currently has an outperform rating on the stock. Several... More of this article »
Image for MidCap Financial Investment (NASDAQ:MFIC) Price Target Lowered to $11.50 at Keefe, Bruyette & Woods

MidCap Financial Investment (NASDAQ:MFIC) Price Target Lowered to $11.50 at Keefe, Bruyette & Woods

MidCap Financial Investment (NASDAQ:MFIC – Free Report) had its target price cut by Keefe, Bruyette & Woods from $13.00 to $11.50 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently... More of this article »
Image for Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at Mizuho

Maze Therapeutics (NASDAQ:MAZE) Now Covered by Analysts at Mizuho

Mizuho assumed coverage on shares of Maze Therapeutics (NASDAQ:MAZE – Free Report) in a research report sent to investors on Tuesday, MarketBeat reports. The brokerage issued an outperform rating and a $97.00 price target on... More of this article »
Image for Day One Biopharmaceuticals (NASDAQ:DAWN) Given Neutral Rating at HC Wainwright

Day One Biopharmaceuticals (NASDAQ:DAWN) Given Neutral Rating at HC Wainwright

HC Wainwright restated their neutral rating on shares of Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The firm currently has a $21.50... More of this article »
Image for Dianthus Therapeutics (NASDAQ:DNTH) Price Target Raised to $132.00 at Robert W. Baird

Dianthus Therapeutics (NASDAQ:DNTH) Price Target Raised to $132.00 at Robert W. Baird

Dianthus Therapeutics (NASDAQ:DNTH – Free Report) had its price objective boosted by Robert W. Baird from $67.00 to $132.00 in a report issued on Tuesday,Benzinga reports. Robert W. Baird currently has an outperform rating on... More of this article »